Vitamin D supplementation: a potential therapeutic agent for metastatic colorectal cancer.

ABSTRACT: Preclinical and epidemiological evidence suggests that vitamin D may have anti-cancer activities in patients with colorectal cancer. A recently completed, randomised Phase 2 trial of vitamin D₃ supplementation in patients with metastatic colorectal cancer has shown promising results, and a Phase 3 trial is currently underway.

SUBMITTER: Yuan C 

PROVIDER: S-EPMC7553965 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature